MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Belnacasan

CAS No. : 273404-37-8

MCE 站：Belnacasan

产品活性：Belnacasan (VX-765) 是 VRT-043198 的口服生物活性前药，VRT-043198 是有效选择性的 IL 转换酶 (ICE)/caspase-1 抑制剂，对 caspase-1 的 K_i 值为 0.8 nM，对 caspase-4 的 K_i 值小于 0.6 nM。Belnacasan (VX-765) 作用于外周血单核细胞，可抑制 LPS 诱导的 IL-1β 和 IL-18 释放，IC₅₀ 约为 0.7 μM。

研究领域：Apoptosis

作用靶点：Caspase

In Vivo: Belnacasan reduces inflammatory response in murine models of inflammatory disease.
Belnacasan (50-200 mg/kg) significantly reduces serum IL-1β levels by as much as 60%. It is noteworthy that the effect of Belnacasan on the release of IL-1β induced by LPS reached a plateau at 100 mg/kg. Belnacasan (25-100 mg/kg × 2) significantly reduces ear edema. Belnacasan also dose-dependently reduces the concentrations of cytokines, chemokines, and inflammatory mediators in the ear biopsy samples.
Belnacasan (25-200 mg/kg) significantly delays the time to seizure onset by 1.5- to twofold (p<0.01), reduces the number of seizures by 40% (p<0.01) and the total time spent in EEG seizure activity by 30 to 50% (p<0.01).

相关产品：Drug Repurposing Compound Library Plus  |  Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  Apoptosis Compound Library  |  Immunology/Inflammation Compound Library  |  Clinical Compound Library  |  Peptidomimetic Library  |  Drug Repurposing Compound Library  |  Pyroptosis Compound Library  |  Orally Active Compound Library  |  Z-VAD(OMe)-FMK  |  Z-DEVD-FMK  |  Z-IETD-FMK  |  Tauroursodeoxycholate Sodium  |  Emricasan  |  Ac-DEVD-CHO  |  Guggulsterone  |  Wedelolactone  |  Z-YVAD-FMK  |  Ginsenoside Rh2  |  Terfenadine  |  Dehydrocorydaline chloride  |  Crustecdysone  |  Phenoxodiol  |  Ac-FLTD-CMK  |  Asperosaponin VI  |  BOC-D-FMK  |  Taurodeoxycholic acid sodium hydrate  |  2-HBA  |  Fenbufen  |  Arnicolide D  |  Z-WEHD-FMK  |  ZYZ-488  |  5,?7,?4'-?Trimethoxyflavone  |  Chelidonic acid  |  Paris saponin VII

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。